TIKOMED AB
556622-8960ActiveDeveloping novel drug candidates for neurodegenerative diseases via partnerships.
Biotechnology / Investment Holding Companytikomed.com
Oversikt
- 1–4
- Ansatte
- 10–20mill SEK
- Omsetning
- 2002
- Grunnlagt
Nøkkelbeslutningstakere
Björn Pilström
Chief Executive Officer
Annika Kollén
Board Member
Henrik Otendal
CFO
Anders Svensson
Board Member
Beskrivelse
TikoMed AB is a privately owned Swedish company established in 2002, focused on groundbreaking scientific innovation in drug development. The core of their work revolves around developing ILB®, a novel molecule demonstrating unique properties in stimulating the body’s natural repair mechanisms. This...